# Kayne Anderson BDC, Inc.: financial statements, quarterly

KBDC · NYSE · CIK 1747172 · [Other](/sectors/other.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/kbdc.md) · [Financials](/companies/kbdc/financials.md) · [Filings](/companies/kbdc/filings.md) · [Insiders](/companies/kbdc/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/kbdc/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating income | $m | [(19.8)](/filings/0001213900-24-097564.md) | [(20.3) d](/filings/0001213900-26-022392.md) | [(22.7)](/filings/0001213900-25-042033.md) | [(18.1)](/filings/0001213900-25-074300.md) | [(20.8)](/filings/0001213900-25-108212.md) | [(22.3) d](/filings/0001213900-26-022392.md) | [(26.5)](/filings/0001193125-26-216773.md) | [(28.6)](/filings/0001193125-26-342385.md) | [(31.3)](/filings/0001213900-25-108212.md) | [(31.8) d](/filings/0001213900-26-022392.md) | [(28.4)](/filings/0001193125-26-216773.md) | [(28.1)](/filings/0001193125-26-342385.md) |
| Interest expense | $m | [13.9](/filings/0001213900-23-086801.md) | [13.9 d](/filings/0001213900-24-018465.md) | [15.7](/filings/0001213900-24-040973.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | not reported | not reported | not reported | not reported | not reported | not reported | [0.6](/filings/0001193125-26-216773.md) | [0.3](/filings/0001193125-26-342385.md) | [0.4](/filings/0001213900-25-108212.md) | [0.3 d](/filings/0001213900-26-022392.md) | [0.4](/filings/0001193125-26-216773.md) | [0.0](/filings/0001193125-26-342385.md) |
| Net income | $m | [13.9](/filings/0001213900-24-097564.md) | [22.8 d](/filings/0001213900-26-022392.md) | [27.8](/filings/0001213900-25-042033.md) | [31.2](/filings/0001213900-25-074300.md) | [37.6](/filings/0001213900-25-108212.md) | [35.4 d](/filings/0001213900-26-022392.md) | [22.2](/filings/0001193125-26-216773.md) | [24.9](/filings/0001193125-26-342385.md) | [24.6](/filings/0001213900-25-108212.md) | [22.0 d](/filings/0001213900-26-022392.md) | [17.2](/filings/0001193125-26-216773.md) | [10.7](/filings/0001193125-26-342385.md) |
| Diluted EPS | $ per share | [0.53](/filings/0001213900-24-097564.md) | not reported | [0.52](/filings/0001213900-25-042033.md) | [0.51](/filings/0001213900-25-074300.md) | [0.52](/filings/0001213900-25-108212.md) | not reported | [0.40](/filings/0001193125-26-216773.md) | [0.40](/filings/0001193125-26-342385.md) | [0.43](/filings/0001213900-25-108212.md) | not reported | [0.43](/filings/0001193125-26-216773.md) | [0.42](/filings/0001193125-26-342385.md) |
| Basic EPS | $ per share | [0.53](/filings/0001213900-24-097564.md) | not reported | [0.52](/filings/0001213900-25-042033.md) | [0.51](/filings/0001213900-25-074300.md) | [0.52](/filings/0001213900-25-108212.md) | not reported | [0.40](/filings/0001193125-26-216773.md) | [0.40](/filings/0001193125-26-342385.md) | [0.43](/filings/0001213900-25-108212.md) | not reported | [0.43](/filings/0001193125-26-216773.md) | [0.42](/filings/0001193125-26-342385.md) |

- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [12.4](/filings/0001213900-23-086801.md) | [34.1](/filings/0001213900-25-019408.md) | [33.4](/filings/0001213900-24-040973.md) | [20.3](/filings/0001213900-24-068355.md) | [39.1](/filings/0001213900-24-097564.md) | [22.4](/filings/0001213900-25-019408.md) | [17.4](/filings/0001213900-25-042033.md) | [14.0](/filings/0001213900-25-074300.md) | [16.4](/filings/0001213900-25-108212.md) | [18.0](/filings/0001193125-26-342385.md) | [14.3](/filings/0001193125-26-216773.md) | [14.5](/filings/0001193125-26-342385.md) |
| Total assets | $m | [1,321](/filings/0001213900-23-086801.md) | [1,424](/filings/0001213900-25-019408.md) | [1,844](/filings/0001213900-24-040973.md) | [1,910](/filings/0001213900-24-068355.md) | [2,028](/filings/0001213900-24-097564.md) | [2,083](/filings/0001213900-26-022392.md) | [2,231](/filings/0001213900-25-042033.md) | [2,256](/filings/0001213900-25-074300.md) | [2,338](/filings/0001213900-25-108212.md) | [2,287](/filings/0001193125-26-342385.md) | [2,252](/filings/0001193125-26-216773.md) | [2,342](/filings/0001193125-26-342385.md) |
| Total liabilities | $m | [640](/filings/0001213900-23-086801.md) | [741](/filings/0001213900-25-019408.md) | [1,033](/filings/0001213900-24-040973.md) | [732](/filings/0001213900-24-068355.md) | [842](/filings/0001213900-24-097564.md) | [896](/filings/0001213900-26-022392.md) | [1,054](/filings/0001213900-25-042033.md) | [1,099](/filings/0001213900-25-074300.md) | [1,198](/filings/0001213900-25-108212.md) | [1,177](/filings/0001193125-26-342385.md) | [1,173](/filings/0001193125-26-216773.md) | [1,282](/filings/0001193125-26-342385.md) |
| Shareholders' equity | $m | [681](/filings/0001213900-24-097564.md) | [683](/filings/0001213900-26-022392.md) | [812](/filings/0001213900-25-074300.md) | [1,178](/filings/0001213900-25-108212.md) | [1,186](/filings/0001213900-25-108212.md) | [1,186](/filings/0001193125-26-342385.md) | [1,177](/filings/0001193125-26-342385.md) | [1,157](/filings/0001193125-26-342385.md) | [1,140](/filings/0001213900-25-108212.md) | [1,110](/filings/0001193125-26-342385.md) | [1,079](/filings/0001193125-26-342385.md) | [1,060](/filings/0001193125-26-342385.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue, us-gaap:Cash
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [21.3 d](/filings/0001213900-24-097564.md) | [(53.8) d](/filings/0001213900-26-022392.md) | [(91.0)](/filings/0001213900-25-042033.md) | [(287) d](/filings/0001213900-25-074300.md) | [(118) d](/filings/0001213900-25-108212.md) | [(49.1) d](/filings/0001213900-26-022392.md) | [(127)](/filings/0001193125-26-216773.md) | [2.4 d](/filings/0001193125-26-342385.md) | [(53.7) d](/filings/0001213900-25-108212.md) | [79.8 d](/filings/0001213900-26-022392.md) | [39.8](/filings/0001193125-26-216773.md) | [(69.4) d](/filings/0001193125-26-342385.md) |
| Dividends paid | $m | not reported | not reported | [20.5](/filings/0001213900-25-042033.md) | not reported | not reported | not reported | [31.5](/filings/0001213900-25-042033.md) | [35.6 d](/filings/0001193125-26-342385.md) | not reported | not reported | [27.2](/filings/0001193125-26-216773.md) | [26.6 d](/filings/0001193125-26-342385.md) |
| Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | [0.4 d](/filings/0001213900-26-022392.md) | [0.4](/filings/0001193125-26-216773.md) | [8.8 d](/filings/0001193125-26-342385.md) | [13.9 d](/filings/0001213900-25-108212.md) | [24.9 d](/filings/0001213900-26-022392.md) | [21.4](/filings/0001193125-26-216773.md) | [3.8 d](/filings/0001193125-26-342385.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock, us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [29.5](/filings/0001213900-23-086801.md) | [35.9](/filings/0001213900-24-040973.md) | [38.9](/filings/0001213900-24-068355.md) | [40.5](/filings/0001213900-24-097564.md) | [45.3](/filings/0001213900-25-042033.md) | [67.4](/filings/0001213900-25-074300.md) | [71.1](/filings/0001213900-25-108212.md) | [71.2](/filings/0001193125-26-216773.md) | [70.9](/filings/0001193125-26-342385.md) | [70.4](/filings/0001213900-25-108212.md) | [67.1](/filings/0001193125-26-216773.md) | [66.3](/filings/0001193125-26-342385.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 66,037,810 at 2026-08-05, from the cover of the [10-Q filed 2026-08-10](/filings/0001193125-26-342385.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:47 ET. No prices; not investment advice.